Hepatitis C Virus
Study results from University of Catania in the area of hepatitis C virus published
Published in Hepatitis Weekly, August 10th, 2009
According to a study from Catania, Italy, "The pegylated interferon (PEG-IFN)/ribavirin combination has been shown to be effective for hepatitis C virus (HCV)-related compensated cirrhosis, but it frequently causes adverse events, leading to premature termination. In this open study we evaluated the safety and efficacy of early retreatment with leukocyte IFN-alpha in Child A HCV genotype 1b-infected cirrhotics intolerant to PEG-IFNs. 61 patients were treated with PEG-IFN (either alpha-2b 1.2-1.5 lg/kg weekly or alpha-2a 180 lg/weekly) plus ribavirin (1,000 mg/day) for 48 weeks."
"During the first 6 months, patients who discontinued treatment because of side effects were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2009-08-10)
More Articles from Hepatitis Weekly
- World Journal of Gastroenterology
Does peripheral T-lymphocyte subpopulations correlate with hepatitis B virus load? - Angiogenesis
Researchers from Nanyang Technological University report on findings in angiogenesis - Antibiotics
Data on antibiotics published by researchers at Ankara University - Fibrosis
Research reports on fibrosis from RWTH Aachen University provide new insights - Hepatitis B Virus
New data from Hunan Normal University illuminate research in hepatitis B virus - Hepatitis B Virus
Reports from University of Witwatersrand add new data to research in hepatitis B virus - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
